{"id":526955,"date":"2021-08-11T16:33:30","date_gmt":"2021-08-11T20:33:30","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\/"},"modified":"2021-08-11T16:33:30","modified_gmt":"2021-08-11T20:33:30","slug":"proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\/","title":{"rendered":"ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Ophthalmology Virtual Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>LEIDEN, Netherlands &amp; CAMBRIDGE, Mass., Aug.  11, 2021  (GLOBE NEWSWIRE) &#8212; ProQR Therapeutics N.V. (Nasdaq: PRQR) (the \u201cCompany\u201d), a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today announced that Company management will present at the upcoming HC Wainwright Ophthalmology Virtual Conference. The presentation will be available on demand on August 17, 2021, at 7:00 am EDT.<\/p>\n<p>An archived webcast of the presentation will be accessible from the \u201cInvestors &amp; Media\u201d section of ProQR\u2019s website (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vCpAn43nMWiqh2T0i7Sbnq2-nrpN5wVSA7JZwB5GUY7KWnoBekIjMtZksYqgBpfpM3uT8er_21Qphd_sb_iUUw==\" rel=\"nofollow noopener\" target=\"_blank\"><strong>www.proqr.com<\/strong><\/a>) under \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MrXBCsAlFzTDNjIR9SYlwVamqUDL9CFn2tN5-vAUmvy4IjAV31VnkodeqLPiaFKhNHf7-fUpg9tr_Oe4xfyQ2g==\" rel=\"nofollow noopener\" target=\"_blank\"><strong>Events<\/strong><\/a>\u201d for approximately 30 days following the presentation date.<\/p>\n<p>\n        <strong>About ProQR<\/strong>\n      <\/p>\n<p>ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA therapies for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis pigmentosa. Based on our unique proprietary RNA repair platform technologies we are growing our pipeline with patients and loved ones in mind. <\/p>\n<p>Learn more about ProQR at <strong>www.proqr.com<\/strong>.<\/p>\n<p>\n        <strong>FORWARD-LOOKING STATEMENTS<\/strong>\n      <\/p>\n<p>This press release contains forward-looking statements. All statements other than statements of historical fact are forward-looking statements, which are often indicated by terms such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;look forward to&#8221;, &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and similar expressions. Such forward-looking statements include, but are not limited to, statements regarding our participation in this conference. Forward-looking statements are based on management&#8217;s beliefs and assumptions and on information available to management only as of the date of this press release. Our actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including, without limitation, the risks, uncertainties and other factors in our filings made with the Securities and Exchange Commission, including certain sections of our annual report filed on Form 20-F. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and we assume no obligation to update these forward-looking statements, even if new information becomes available in the future, except as required by law.<\/p>\n<p>\n        <strong>ProQR Therapeutics N.V.<\/strong>\n      <\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Sarah Kiely<br \/>ProQR Therapeutics N.V.<br \/>T: +1 617 599 6228<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Tka60KY49ClVoD6VXdP1rGicXQrJiK_Q1521wuUzYE5PPCkqUPsQu7TN4ZF8oGZ9oTNkB8UaJFNgexPQC45y4A==\" rel=\"nofollow noopener\" target=\"_blank\"><strong>skiely@proqr.com<\/strong><\/a><br \/>or<br \/>Hans Vitzthum<br \/>LifeSci Advisors<br \/>T: +1 617 430 7578<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VNCDSVx0OYaXTiU1DW0SDJqKqllM-FB6v2NU4kKl-Q0GCnZMaCzAiTBeDdhDEFfm2j6B4X47q2XN5iAlApuYWfRHq_MaL35Tmfij3JSlsKg=\" rel=\"nofollow noopener\" target=\"_blank\"><strong>hans@lifesciadvisors.com<\/strong><\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Cherilyn Cecchini, MD<br \/>LifeSci Communications<br \/>T: +1 646 876 5196<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1yWGB3MQ5Un9AgndfJ0r3J5jd2tcgqyfsmJxpdP058WealB3BwWUpzN97_5yaeC5ns-Xus8s4Rg4VkuibxYkBIWagAlhnPMZ8wDDOIW3vL3vl5WTrDaufcF6eho1DHSa\" rel=\"nofollow noopener\" target=\"_blank\"><strong>ccecchini@lifescicomms.com<\/strong><\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUzMTEyNSM0MDEwMTY0ODgjMjAxMTE2Nw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/OWEwNmQzMDUtNjhiYS00OWM4LTk1N2EtZTNjYTA1MTM1ODNhLTEwMjI3NDA=\/tiny\/ProQR-Therapeutics-N-V-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LEIDEN, Netherlands &amp; CAMBRIDGE, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) &#8212; ProQR Therapeutics N.V. (Nasdaq: PRQR) (the \u201cCompany\u201d), a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today announced that Company management will present at the upcoming HC Wainwright Ophthalmology Virtual Conference. The presentation will be available on demand on August 17, 2021, at 7:00 am EDT. An archived webcast of the presentation will be accessible from the \u201cInvestors &amp; Media\u201d section of ProQR\u2019s website (www.proqr.com) under \u201cEvents\u201d for approximately 30 days following the presentation date. About ProQR ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA therapies for the treatment of severe genetic rare diseases such as &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Ophthalmology Virtual Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-526955","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Ophthalmology Virtual Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Ophthalmology Virtual Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LEIDEN, Netherlands &amp; CAMBRIDGE, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) &#8212; ProQR Therapeutics N.V. (Nasdaq: PRQR) (the \u201cCompany\u201d), a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today announced that Company management will present at the upcoming HC Wainwright Ophthalmology Virtual Conference. The presentation will be available on demand on August 17, 2021, at 7:00 am EDT. An archived webcast of the presentation will be accessible from the \u201cInvestors &amp; Media\u201d section of ProQR\u2019s website (www.proqr.com) under \u201cEvents\u201d for approximately 30 days following the presentation date. About ProQR ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA therapies for the treatment of severe genetic rare diseases such as &hellip; Continue reading &quot;ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Ophthalmology Virtual Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-11T20:33:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUzMTEyNSM0MDEwMTY0ODgjMjAxMTE2Nw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Ophthalmology Virtual Conference\",\"datePublished\":\"2021-08-11T20:33:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\\\/\"},\"wordCount\":372,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDUzMTEyNSM0MDEwMTY0ODgjMjAxMTE2Nw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\\\/\",\"name\":\"ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Ophthalmology Virtual Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDUzMTEyNSM0MDEwMTY0ODgjMjAxMTE2Nw==\",\"datePublished\":\"2021-08-11T20:33:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDUzMTEyNSM0MDEwMTY0ODgjMjAxMTE2Nw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDUzMTEyNSM0MDEwMTY0ODgjMjAxMTE2Nw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Ophthalmology Virtual Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Ophthalmology Virtual Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\/","og_locale":"en_US","og_type":"article","og_title":"ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Ophthalmology Virtual Conference - Market Newsdesk","og_description":"LEIDEN, Netherlands &amp; CAMBRIDGE, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) &#8212; ProQR Therapeutics N.V. (Nasdaq: PRQR) (the \u201cCompany\u201d), a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today announced that Company management will present at the upcoming HC Wainwright Ophthalmology Virtual Conference. The presentation will be available on demand on August 17, 2021, at 7:00 am EDT. An archived webcast of the presentation will be accessible from the \u201cInvestors &amp; Media\u201d section of ProQR\u2019s website (www.proqr.com) under \u201cEvents\u201d for approximately 30 days following the presentation date. About ProQR ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA therapies for the treatment of severe genetic rare diseases such as &hellip; Continue reading \"ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Ophthalmology Virtual Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-11T20:33:30+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUzMTEyNSM0MDEwMTY0ODgjMjAxMTE2Nw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Ophthalmology Virtual Conference","datePublished":"2021-08-11T20:33:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\/"},"wordCount":372,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUzMTEyNSM0MDEwMTY0ODgjMjAxMTE2Nw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\/","name":"ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Ophthalmology Virtual Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUzMTEyNSM0MDEwMTY0ODgjMjAxMTE2Nw==","datePublished":"2021-08-11T20:33:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUzMTEyNSM0MDEwMTY0ODgjMjAxMTE2Nw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUzMTEyNSM0MDEwMTY0ODgjMjAxMTE2Nw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/proqr-announces-webcast-of-presentation-at-upcoming-hc-wainwright-ophthalmology-virtual-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Ophthalmology Virtual Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/526955","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=526955"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/526955\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=526955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=526955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=526955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}